Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC24H22ClF3N4O |
InChIKeyDLQYUPNLYDQQCG-UHFFFAOYSA-N |
CAS Registry1977540-49-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | - |